ASAM Pocket Guidelines and Patient Guide

Stimulant Use Disorder

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1519511

Contents of this Issue

Navigation

Page 4 of 29

5 Comprehensive Assessment 2. After first addressing any urgent biomedical or psychiatric signs or symptoms, patients should undergo a comprehensive assessment that includes: a. assessment for StUD based on diagnostic criteria (eg, current Diagnostic and Statistical Manual of Mental Disorders [DSM]); CC-S); b. a StUD-focused history and physical examination (CC-S); c. a mental status exam to identify co-occurring psychiatric conditions, such as signs and symptoms of psychosis, ADHD, mood or anxiety disorders, cognitive impairment, and risk of harm to self or others (CC-S); and d. a full biopsychosocial assessment (CC-S). 3. Clinicians treating StUD should conduct routine baseline laboratory testing (CC-S). a. Clinicians should conduct other clinical tests as necessary based on each patient's clinical assessment findings (CC-C). In non-acute care settings, clinicians should order the following clinical tests for most patients: • Complete blood count (CBC) • Comprehensive metabolic panel (CMP) (eg, renal panel, liver function test [LFTs]) • Screening for infectious diseases in accordance with current guidance • HIV and HCV for all patients • Hepatitis B virus (HBV) for patients at increased risk for infection • Screening for STIs (eg, gonorrhea, chlamydia, syphilis) • Pregnancy testing for all patients with childbearing potential Clinicians can also consider ordering the following clinical tests: • Tuberculosis (TB) for patients at increased risk for infection • HAV for patients at increased risk for infection • Other clinical tests as necessary based on clinical assessment, such as creatine kinase (CK) if signs of rhabdomyolysis are present (eg, increased muscle tone/rigidity, elevated temperature) 4. When evaluating patients with long-term or heavy stimulant use, clinicians should exercise: a. an elevated degree of suspicion for cardiac disorders (CC-C), b. a lower threshold for considering electrocardiogram (ECG) testing based on findings of the history and physical exam (CC-C), c. a lower threshold for considering CK testing for rhabdomyolysis based on history and physical exam findings (CC-S), and d. an elevated degree of suspicion for renal disorders (CC-C).

Articles in this issue

view archives of ASAM Pocket Guidelines and Patient Guide - Stimulant Use Disorder